Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial will study the safety and efficacy of intravenous and intracavernosal or interstitial delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Peyronie's disease, erectile dysfunction , and Interstitial Cystitis
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-11-29; most recent amendment 2025-04-15.
Trial Details
NCT Number NCT05147779
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Erectile Dysfunction, Peyronie's Disease, Interstitial Cystitis
Enrollment 20 participants
Start Date 2021-09-12
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-17